REGENXBIO Inc. (RGNX) Insider Trading
Directors, officers and holders of more than 10% of RGNX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 112 transactions on file: 2 with code P, 5 with code S and 43 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Malzahn Craig | Chief Technology Officer | F Tax Payment | 234 | $9.32 | $2,181 |
| Sep 1, 2026 | Chan Mitchell | Chief Financial Officer | F Tax Payment | 4,902 | $9.32 | $45,687 |
| Aug 27, 2026 | Ciongoli Gregory Austin | Director | P Purchase | 53,407 | $9.36 | $499,676 |
| Aug 26, 2026 | Ciongoli Gregory Austin | Director | P Purchase | 49,196 | $9.14 | $449,706 |
| Aug 25, 2026 | Ciongoli Gregory Austin | Director | A Award | 15,432 | Not measured | Not measured |
| Aug 25, 2026 | Ciongoli Gregory Austin | Director | A Award | 69,609 | Not measured | Not measured |
| Aug 1, 2026 | PAKOLA STEVE | Chief Medical Officer | F Tax Payment | 7,468 | $9.69 | $72,365 |
| Aug 1, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | F Tax Payment | 4,699 | $9.69 | $45,533 |
| Jul 2, 2026 | PAKOLA STEVE | Chief Medical Officer | M Exercise | 2,161 | Not measured | Not measured |
| Jul 2, 2026 | PAKOLA STEVE | Chief Medical Officer | S Sale | 2,161 | $13.64 | $29,476 |
| Jul 2, 2026 | PAKOLA STEVE | Chief Medical Officer | M Exercise | 2,161 | $7.86 | $16,985 |
| Jul 1, 2026 | Simpson Curran | Chief Executive Officer | F Tax Payment | 6,818 | $13.09 | $89,248 |
| Jul 1, 2026 | PAKOLA STEVE | Chief Medical Officer | S Sale | 36,725 | $12.86 | $472,284 |
| Jul 1, 2026 | PAKOLA STEVE | Chief Medical Officer | M Exercise | 36,725 | Not measured | Not measured |
| Jul 1, 2026 | PAKOLA STEVE | Chief Medical Officer | M Exercise | 36,725 | $7.86 | $288,659 |
| Jun 30, 2026 | Simpson Curran | Chief Executive Officer | A Award | 1,453 | $10.18 | $14,792 |
| Jun 29, 2026 | PAKOLA STEVE | Chief Medical Officer | S Sale | 19,608 | $11.04 | $216,472 |
| May 29, 2026 | Bennett Jean | Director | A Award | 46,600 | Not measured | Not measured |
| May 29, 2026 | STUMP DAVID C | Director | A Award | 9,807 | Not measured | Not measured |
| May 29, 2026 | STUMP DAVID C | Director | A Award | 46,600 | Not measured | Not measured |
| May 29, 2026 | MIGAUSKY GEORGE V | Director | A Award | 9,807 | Not measured | Not measured |
| May 29, 2026 | Glucksmann Alexandra | Director | A Award | 46,600 | Not measured | Not measured |
| May 29, 2026 | KARABELAS ARGERIS N | Director | A Award | 46,600 | Not measured | Not measured |
| May 29, 2026 | Zachary Jennifer | Director | A Award | 46,600 | Not measured | Not measured |
| May 29, 2026 | Tasse Daniel | Director | A Award | 46,600 | Not measured | Not measured |
| May 29, 2026 | Mills Kenneth T. | Director | A Award | 9,807 | Not measured | Not measured |
| May 29, 2026 | MIGAUSKY GEORGE V | Director | A Award | 46,600 | Not measured | Not measured |
| May 29, 2026 | Glucksmann Alexandra | Director | A Award | 9,807 | Not measured | Not measured |
| May 29, 2026 | KARABELAS ARGERIS N | Director | A Award | 9,807 | Not measured | Not measured |
| May 29, 2026 | Fox Allan M. | Director | A Award | 9,807 | Not measured | Not measured |
| May 29, 2026 | Mills Kenneth T. | Director | A Award | 46,600 | Not measured | Not measured |
| May 29, 2026 | Tasse Daniel | Director | A Award | 9,807 | Not measured | Not measured |
| May 29, 2026 | Zachary Jennifer | Director | A Award | 9,807 | Not measured | Not measured |
| May 29, 2026 | Fox Allan M. | Director | A Award | 46,600 | Not measured | Not measured |
| May 29, 2026 | Bennett Jean | Director | A Award | 9,807 | Not measured | Not measured |
| May 11, 2026 | PAKOLA STEVE | Chief Medical Officer | S Sale | 15,309 | $11.02 | $168,705 |
| Mar 10, 2026 | PAKOLA STEVE | Chief Medical Officer | S Sale | 5,124 | $10.35 | $53,033 |
| Feb 1, 2026 | PAKOLA STEVE | Chief Medical Officer | F Tax Payment | 5,267 | $11.16 | $58,780 |
| Feb 1, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | F Tax Payment | 4,700 | $11.16 | $52,452 |
| Jan 27, 2026 | Mills Kenneth T. | Director | M Exercise | 225,000 | Not measured | Not measured |
| Jan 27, 2026 | Mills Kenneth T. | Director | M Exercise | 225,000 | $13.09 | $2,945,250 |
| Jan 27, 2026 | Mills Kenneth T. | Director | F Tax Payment | 221,753 | $13.41 | $2,973,708 |
| Jan 6, 2026 | Malzahn Craig | Chief Technology Officer | A Award | 65,847 | Not measured | Not measured |
| Jan 6, 2026 | Christmas Patrick J. | Chief Strategy & Legal Officer | A Award | 73,749 | Not measured | Not measured |
| Jan 6, 2026 | Simpson Curran | Chief Executive Officer | A Award | 233,651 | Not measured | Not measured |
| Jan 6, 2026 | Simpson Curran | Chief Executive Officer | A Award | 144,864 | Not measured | Not measured |
| Jan 6, 2026 | Chan Mitchell | Chief Financial Officer | A Award | 39,650 | Not measured | Not measured |
| Jan 6, 2026 | Chan Mitchell | Chief Financial Officer | A Award | 73,749 | Not measured | Not measured |
| Jan 6, 2026 | PAKOLA STEVE | Chief Medical Officer | A Award | 65,847 | Not measured | Not measured |
| Jan 6, 2026 | PAKOLA STEVE | Chief Medical Officer | A Award | 35,402 | Not measured | Not measured |
The full Form 4 history is on the RGNX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.